peplomycin - CISMeF

Preferred Label : peplomycin;

MeSH definition : An antineoplastic agent derived from BLEOMYCIN.;

MeSH synonym : pepleomycin;

CISMeF synonym : 70384-29-1 (Peplomycin sulfate (1:1)); 73228-94-1 (Peplomycin sulfate);

MeSH hyponym : NK-631; peplomycin sulfate; NK 631; NK631; Sulfate, Peplomycin; Peplomycin Sulfate (1:1);

MeSH CAS label : bleomycinamide, N1-(3-((1-phenylethyl)amino)propyl)-, (S)-;

MeSH Related Number : peplomycin sulfate; 68247-85-8 (Peplomycin); 73228-94-1 (unspecified sulfate); 6A668951HW;

Registry Number MeSH : 68247-85-8;

Related CAS MeSH : 6A668951HW (Peplomycin sulfate);

Codes EINECS : 269-484-0;

Is substance : O;

UNII : 56H9L80NIZ;

InChIKey : QIMGFXOHTOXMQP-GFAGFCTOSA-N;

Details

Origin ID

D017663;

UMLS CUI

C0135981;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Peplomycin [ICHI extension code]
- Peplomycin Sulfate [NCIt concept]
- bleomycinamide, n1-[3-[(1-phenylethyl)amino]propyl]-, (s)-, sulfate (1:1) (salt) [Substance BNPC]
CISMeF manual mappings
- peplomycin [Substance BNPC]
Currated CISMeF NLP mapping
- Peplomycin [ICD-11 Extension code]
- Peplomycin [NCIt concept]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
Record concept(s)
- NK-631 [MeSH concept]
- peplomycin [MeSH concept]
- peplomycin sulfate [MeSH concept]
Related MeSH Supplementary Concept(s)
- CAP therapy protocol [MeSH Supplementary Concept]
- COMPA regimen [MeSH Supplementary Concept]
- COMPE protocol [MeSH Supplementary Concept]
- PAV protocol [MeSH Supplementary Concept]
- PEP protocol [MeSH Supplementary Concept]
- PFAP protocol [MeSH Supplementary Concept]
- POMP regimen [MeSH Supplementary Concept]
- PPA protocol [MeSH Supplementary Concept]
- PPM protocol [MeSH Supplementary Concept]
- PTP protocol [MeSH Supplementary Concept]
- PVP protocol 4 [MeSH Supplementary Concept]
- VIP regimen 2 [MeSH Supplementary Concept]
- VMP-CIsCF protocol [MeSH Supplementary Concept]
- VPCP protocol [MeSH Supplementary Concept]
See also inter- (CISMeF)
- bleomycinamide, n1-[3-[(1-phenylethyl)amino]propyl]-, (s)-, sulfate (1:1) (salt) [Substance BNPC]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Antibiotic [UMLS semantic type]
UMLS correspondences (same concept)
- Peplomycin [ICD-11 Extension code]
- Peplomycin [NCIt concept]
- peplomycin [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients